Composition and kit for detecting EGFR gene deletion mutation, and detection method
A technology for mutation detection and gene deletion, applied in the field of biomedical nucleic acid detection, can solve the problems of unfavorable clinical application, high modification price, and high quantification of mutation abundance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0124] A composition for detection of EGFR gene exon 19 deletion mutation comprises:
[0125] Composition for mutation detection:
[0126] The upstream primer F1 has a nucleotide sequence as shown in SEQ ID NO.1;
[0127] The upstream primer F1-1 has a nucleotide sequence as shown in SEQ ID NO.3;
[0128] Hydrolysis probe P1 has the nucleotide sequence shown in SEQ ID NO.5;
[0129] Downstream primer R has a nucleotide sequence as shown in SEQ ID NO.7;'
[0130] Compositions for wild type detection:
[0131] The upstream primer F2 has a nucleotide sequence as shown in SEQ ID NO.2;
[0132] The upstream primer F2-1 has a nucleotide sequence as shown in SEQ ID NO.4;
[0133] Hydrolysis probe P2 has the nucleotide sequence shown in SEQ ID NO.6;
[0134]The downstream primer R has the nucleotide sequence shown in SEQ ID NO.7.
[0135] The 5' end of the hydrolysis probe P1 is labeled with a FAM fluorescent group, the 5' end of the hydrolysis probe P2 is labeled with a HEX fl...
Embodiment 2
[0142] A kit for detecting deletion mutation of exon 19 of EGFR gene. The kit includes primer-probe premix, reaction buffer, negative control, positive control and blank control. The main components of the components are shown in Table 1.
[0143] The primer probe premix in the kit is the mixture obtained by mixing the composition of Example 1 according to the ratio in Table 3;
[0144] The negative control is a fragmented healthy human genomic DNA sample, which has been sequenced to confirm that there is no deletion mutation in exon 19 of the EGFR gene. During preparation, it was quantified by digital PCR and prepared into a negative control substance of 20,000 copies / μL using Tris-EDTA buffer. Specific as Figure 4 shown.
[0145] The positive control is the DNA sample of the fragmented NCI-H1650 mutant cell line, which contains the EGFR gene exon 19 deletion mutation, specifically the mutation subtype is delE746-A750; the specific base level is c.2235_2249del15 (Cosmic ID:...
Embodiment 3
[0150] Perform assays on cell line samples.
[0151] Sample preparation:
[0152] Using QIAGEN Corporation The DNA Mini Kit was used to extract the nucleic acid of the NCI-H1650 cell line containing the mutation deletion of exon 19 of the EGFR gene according to the operation instructions of the kit, and the genomic DNA of the cell line with the mutation deletion of exon 19 of the EGFR gene was obtained.
[0153] Reaction preparation:
[0154] After the sample preparation is completed, the configuration of the reaction system is carried out, and the PCR reaction system is prepared according to the ratio described in Table 3.
[0155] At the same time, the EGFR WT&E746_A750del Assay Kit (Cat. No. 10041170) from Bio-Rad was used as a contrast reagent.
[0156] Add 20 μL of the prepared PCR reaction system to the sample well of the micro-droplet generator card, then add 70 μL of micro-droplet generator oil to the oil hole of the micro-droplet generator card, and finally seal t...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com